Table 2.

Highest grade adverse event observed in 10 patients during Ad.CMV‐p53

Adverse events	Grade 1	Grade 2	Grade 3	Grade 4	Total
Fever (%)	1 (10)	9 (90)	0	0	10 (100)
Pain (%)	1 (10)	2 (20)	0	0	3 (30)
Hyperglycemia (%)	3 (30)	0	0	0	3 (30)
Hypocalcemia (%)	2 (20)	0	0	0	2 (20)
APTT elongation (%)	1 (10)	0	0	0	1 (10)
High serum amylase (%)	1 (10)	0	0	0	1 (10)
High serum creatinine (%)	1 (10)	0	0	0	1 (10)

APTT, activated partial thromboplastin time.